We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01218360
First Posted: October 11, 2010
Last Update Posted: March 19, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
  Purpose
This is an observational study to determine the prevalence of moderate to severe Crohn's disease (CD) among patients with active CD and to evaluate existing therapeutic trends in a standard clinical practice.

Condition Intervention
Crohn Disease Drug: Physician standard-of-care

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study on Disease Severity, Evaluation Tools and the Long Term Impact of Each Treatment Strategy in the Daily Clinical Practice in Patients With Moderate to Severe Active Crohn's Disease (Protocol P06484)

Resource links provided by NLM:


Further study details as provided by Merck Sharp & Dohme Corp.:

Primary Outcome Measures:
  • Percentage of Crohn's disease participants among the study population with a Crohn's Disease Activity Index (CDAI) score of 220-450 at the enrollment to the study. [ Time Frame: Week 0 ]
  • Record of treatment strategy followed [ Time Frame: Week 0 to 2 years ]
  • Change in the CDAI score during the observational period [ Time Frame: Week 0 to 2 years ]

Secondary Outcome Measures:
  • Number of surgeries and hospitalizations during the observational period [ Time Frame: Week 0 to 2 years ]

Enrollment: 71
Study Start Date: November 2011
Study Completion Date: January 2015
Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Participants
All participants enrolled
Drug: Physician standard-of-care
Participants will be treated according to their physician's routine practice and the respective Summary of Product Characteristics (SmPC).

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants with diagnosed active Crohn's Disease who are inadequately controlled with their current therapy
Criteria

Inclusion Criteria

  1. Must have a diagnosis of active Crohn's Disease irrespective of severity,
  2. Must be inadequately controlled with their current therapy and for whom physician

    decides to switch treatment.

  3. Must be between 18 and 65 years of age, of either sex,
  4. Must demonstrate willingness to participate in the study by signing the written informed consent.

Exclusion Criteria

  • No specific exclusion criteria will be applied to a participant as long as the participant is eligible for the trial
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier: NCT01218360     History of Changes
Other Study ID Numbers: P06484
First Submitted: October 7, 2010
First Posted: October 11, 2010
Last Update Posted: March 19, 2015
Last Verified: March 2015

Keywords provided by Merck Sharp & Dohme Corp.:
Crohn's disease
standard-of-care
Crohn Disease
Active Crohn's Disease

Additional relevant MeSH terms:
Crohn Disease
Inflammatory Bowel Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases